Evidence map›Paper›PMID 32342331›Full record

ArticleJournal of neuro-oncology2020

Clinical characteristics and prognostic factors of adult patients with pilocytic astrocytoma.

Maximilian J Mair, Adelheid Wöhrer, Julia Furtner, Anika Simonovska, Barbara Kiesel, Stefan Oberndorfer, Karl Ungersböck, Christine Marosi, Felix Sahm, Johannes A Hainfellner and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of neuro-oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 41 citations in OpenAlex.

  1. Clinical potential of [European journal of nuclear medicine and molecular imaging · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Pilocytic astrocytoma: A rare case report.Radiology case reports · 2025
    Article
  9. Article
  10. Article
  11. Review
  12. Magnetic resonance imaging characteristics of pediatric pilocytic astrocytoma.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2023
    Article
  13. Article
  14. Comparison of the clinical features and treatment outcomes of pilocytic astrocytoma in pediatric and adult patients.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Maximilian J MairDivision of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0002-6537-3874
Adelheid WöhrerDivision of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Vienna, Austria.
Julia FurtnerDepartment of Radiology and Biomedical Imaging, Medical University of Vienna, Vienna, Austria.
Anika SimonovskaDivision of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Barbara KieselDepartment of Neurosurgery, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
Stefan OberndorferDepartment of Neurology, University Clinic of St. Pölten, St. Pölten, Austria.
Karl UngersböckDepartment of Neurosurgery, University Clinic of St. Pölten, St. Pölten, Austria.
Christine MarosiDivision of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Felix SahmDepartment of Neuropathology, Institute of Pathology, Ruprecht-Karls University Heidelberg, and Clinical Cooperation Unit Neuropathology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
Johannes A HainfellnerDivision of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Vienna, Austria.
Karl RösslerDepartment of Neurosurgery, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
Matthias PreusserDivision of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Georg WidhalmDepartment of Neurosurgery, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria. georg.widhalm@meduniwien.ac.at.
Anna S BerghoffDivision of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Medical University of Vienna · ATUniversity of Applied Sciences St Pölten · ATGerman Cancer Research Center · DE

Funding

Else Kröner-Fresenius-Stiftung Excellence ProgramMedizinische Universität Wien (research budget)
6 · The paper itself

Abstract

introductionPilocytic astrocytoma (PA) is the most common primary brain neoplasm in children and treated in curative intent with gross total resection (GTR). However, PA is rare in adults, resulting in limited knowledge on the natural clinical course. This study aimed to describe the clinical course and identify prognostic factors of adult patients with PA.

methods46 patients ≥ 18 years at diagnosis of PA and neurosurgical resection or biopsy between 2000 and 2018 were identified from the Neuro-Biobank of the Medical University of Vienna. In two cases with differing histopathological diagnosis at recurrence, DNA methylation analysis was performed using Illumina Infinium HumanMethylation850 BeadChip (850 k) arrays and the Molecular Neuropathology classifier. Clinico-pathological features were correlated with patient outcomes.

resultsMedian age at diagnosis was 32.5 years (range: 19-75) and median Ki67 proliferation index was 2.8% (0.5-13.4%). Tumor location significantly correlated with resectability (p < 0.001). Tumor progression or recurrence was observed in 9/46 (19.6%) patients after a median follow up time of 53.0 months (range 0.5-300). 5-year overall and progression-free survival rates were 85.3% and 70.0%, respectively. 2/9 (22.2%) patients presented with histological changes in the recurrent tumor specimen. In detail, methylation classification redefined the histological diagnosis to anaplastic astrocytoma with piloid features and glioma in one patient, each. Age > 40 and higher body mass index (BMI) were associated with impaired progression-free and overall survival (p < 0.05).

conclusionsTumor recurrence or progression in adult PA patients was higher than the one reported in pediatric patients. Higher age and BMI were associated with impaired prognosis.

Indexed as

AdultAgedAstrocytomaBrain NeoplasmsDisease ProgressionFemaleHumansKaplan-Meier EstimateMaleMiddle AgedPrognosisTreatment OutcomeYoung AdultAdultLow-grade gliomaPilocytic astrocytomaPrimary CNS tumor

Identifiers

PMID32342331
PMCPMC7280326
OpenAlexW3019155655

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.